Table 2.

Patients' treatment and outcome.

	All patients (n = 10)	Death patients (n = 3)	Survivors (n = 7)	p value∗
Antibiotic therapy, n (%)	6 (60)	3 (100)	3 (43)	0.2
Cephalosporin (third generation)	3 (30)	2 (50)	1 (14.3)	0.2
Macrolide	1 (10)	—	1 (14.3)	1
Carbapenems	4 (40)	3 (100)	1 (14.3)	0.03
Others	3 (30)	2 (66.7)	1 (14.3)	0.2
Steroids, n (%)	6 (60)	3 (100)	3 (43)	0.2
Anakinra, n (%)	1 (10)	1 (33.3)	0	0.3
Tocilizumab, n (%)	0	0	0
High flow oxygen therapy >30 lpm, n (%)	4 (40)	3 (100)	1 (14.3)	0.03
Anticoagulation, n (%)	5 (50)	3 (100)	2 (28.6)	0.2

Data are shown as number and percentage. ^∗Chi-square/Fisher's exact test.